Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 394

Payleven and SumUp mobilise to form new company

The Europe-based mobile payment technology providers, collectively backed by Groupon, Amex, Tengelmann, BBVA and MePay, have agreed a merger deal.

Apr 28, 2016

Idinvest to make healthy return from Withings acquisition

Nokia is set to buy digital health product maker Withings, which had raised almost $34m from backers including Idinvest Partners, for $193m.

Apr 26, 2016

Spin Master wins Bonnier startups

Toca Boca and Sago Mini, two game developers established by media company Bonnier, are set to be acquired by digital toy producer Spin Master.

Apr 26, 2016

Zhubaijia boards Chinese public markets

HNA Tourism and Legend-backed holiday home rental portal Zhubaijia has listed on China's Neeq exchange.

Apr 26, 2016

Tencent-backed eJiaJie completes Neeq listing

The app-based home cleaning service has floated on the National Equities Exchange and Quotations market after raising four rounds of funding from investors including Tencent and Shanda.

Apr 21, 2016

Gemphire lights IPO fuse

The dyslipidemia treatment developer has filed for a $60m initial public offering that will allow Pfizer, from which it licensed its lead candidate, to exit.

Apr 21, 2016

Asahi Shimbun goes native with Somewrite acquisition

Gree's corporate venturing unit will exit native advertising technology developer Somewrite, 18 months after taking part in its $1.1m seed round.

Apr 20, 2016

Qorvo reaches GreenPeak to give Bosch an exit

Robert Bosch is set to exit RF technology company GreenPeak, which also counted Motorola Venture Capital as an investor, in an acquisition by Qorvo.

Apr 20, 2016

Shuddle comes back down to earth

The Comcast-backed, child-focused ride hailing service has shut down after failing to find investors willing to provide more funding.

Apr 19, 2016

Public markets lose sight of GenSight IPO

Eye disease therapy developer GenSight Biologics, which had raised almost $78m from investors including Novartis, has withdrawn an IPO expected to raise up to $70m.

Apr 19, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here